Dai Ogata Selected Research

Dai Ogata Research Topics

Disease

24	Melanoma (Melanoma, Malignant) 06/2024 - 08/2016
16	Neoplasms (Cancer) 02/2024 - 06/2010
8	Neoplasm Metastasis (Metastasis) 12/2023 - 08/2014
4	Extramammary Paget Disease (Paget Disease, Extramammary) 08/2023 - 12/2015
4	Lymphatic Metastasis 01/2023 - 12/2015
3	Merkel Cell Carcinoma 07/2023 - 12/2020
3	Hemorrhage 01/2023 - 01/2022
3	Hemangiosarcoma (Angiosarcoma) 01/2023 - 10/2016
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2023 - 09/2022
2	Pain (Aches) 01/2023 - 01/2023
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2021 - 01/2019
2	Disease Progression 11/2020 - 10/2016
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2020 - 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 06/2024
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 12/2023
1	Mucositis 01/2023
1	Dermatitis 01/2023
1	Adenosquamous Carcinoma 01/2023
1	Thyrotoxicosis 09/2022
1	Hypophysitis 09/2022
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 09/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2022
1	Colitis 01/2022
1	Enterocolitis 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022
1	Colonic Neoplasms (Colon Cancer) 02/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Nevus (Nevi) 07/2018
1	Carcinoma (Carcinomatosis) 06/2018
1	Hemangioma (Angioma) 01/2016
1	Eosinophilia 10/2008

Drug/Important Bio-Agent (IBA)

5	Immune Checkpoint InhibitorsIBA 02/2024 - 11/2020
5	NivolumabIBA 04/2023 - 11/2020
3	IpilimumabIBA 04/2023 - 11/2020
2	dabrafenibIBA 05/2024 - 11/2023
2	trametinibIBA 05/2024 - 11/2023
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 06/2021
2	AntibodiesIBA 09/2022 - 01/2021
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2020
2	Bexarotene (LGD1069)FDA Link 06/2020 - 01/2019
2	Docetaxel (Taxotere)FDA Link 01/2020 - 12/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2024
1	SOX9 Transcription FactorIBA 11/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	pembrolizumabIBA 01/2023
1	MAP Kinase Kinase 1IBA 01/2023
1	avelumabIBA 10/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2022
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 09/2022
1	5-((glucopyranosyloxy)methyl)uracilIBA 09/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	CTLA-4 AntigenIBA 01/2022
1	Panitumumab (Vectibix)FDA Link 02/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2021
1	Macrophage Migration-Inhibitory FactorsIBA 12/2020
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 12/2020
1	RetinoidsIBA 01/2019
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2019
1	Prostaglandin-E SynthasesIBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 07/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2018
1	Interferon-betaIBA 07/2017
1	taxaneIBA 10/2016
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2016
1	pazopanib FDA Link 10/2016
1	Immunoglobulin E (IgE)IBA 10/2008

Therapy/Procedure

21	Therapeutics 06/2024 - 08/2014
7	Radiotherapy 12/2023 - 01/2022
6	Lymph Node Excision (Lymph Node Dissection) 07/2023 - 08/2014
5	Immunotherapy 01/2023 - 01/2019
3	Drug Therapy (Chemotherapy) 08/2023 - 12/2015
1	Adjuvant Radiotherapy 06/2024
1	Brachytherapy 01/2023
1	Minimally Invasive Surgical Procedures 01/2023
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022
1	Aftercare (After-Treatment) 12/2020
1	Operative Surgical Procedures 12/2017
1	Free Tissue Flaps 06/2010